Description:
IGF DES(1-3), short for Insulin-like Growth Factor Des(1-3), is a synthetic peptide derived from the insulin-like growth factor-1 molecule. Unlike the full-length IGF-1, IGF DES(1-3) is a truncated version containing only the first three amino acids of the IGF DES(1-3) protein sequence. This modification renders IGF DES(1-3) more resistant to degradation by proteases and enhances its biological activity and specificity.
Mechanism of Action:
The mechanism of action of IGF DES(1-3) intricately involves its interaction with cellular receptors and the orchestration of intracellular signaling pathways. By elucidating the molecular events underlying its activity, researchers gain deeper insights into the fundamental processes governing cellular growth, differentiation, and metabolic regulation.
Contraindications:
Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or preproliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment.
Precautions:
Monitor thyroid function and assess for benign intracranial hypertension. In patients with diabetes mellitus, a reduction in insulin dosage may be necessary. In the case of pregnancy, discontinue treatment if there are signs of tumor growth. Regular monitoring is advised for patients with scoliosis due to the potential risk of its progression.
Drug interactions:
High doses of corticosteroid may inhibit growth-promoting effects of IGF DES.
Dosage:
For adults with SC IGF-1 deficiency, the initial recommended dosage is 4 mcg/kg/day, with the possibility of gradual dose adjustments based on clinical response or tolerance, up to a maximum of 10 mcg/kg/day. In the context of HIV-associated wasting or cachexia, a higher starting dose of 5 mcg/kg/day is advised, preferably administered at bedtime. It is important to note that the administration of IGF-1 can be done multiple times throughout the day to optimize therapeutic effects and accommodate individual patient needs. Careful monitoring and dose adjustments are crucial to ensure efficacy while minimizing potential side effects.
Storage:
Minimize open air exposure, store in a cool dry place. Keep out of reach of children.
Regulatory Compliance Statements:
- This product complies with relevant regulatory guidelines.
- Certified under Good Manufacturing Practices (GMP).
Safety Information:
- Overdose Instructions: In case of overdose, seek immediate medical attention.
- Adverse Reactions: Report any adverse reactions to your healthcare provider.
Both “IGF-1 DES” and “DES (1-3)” refer to the exact same peptide product. The naming differences are purely stylistic or contextual, not biological or chemical. Boxes might highlight either term based on regional regulations or target audiences (e.g., “DES (1-3)” in academic contexts vs. “IGF-1 DES” for bodybuilders).
There are no reviews yet.